Susquehanna International Group
NVAX icon

Susquehanna International Group’s Novavax NVAX Stock Holding History

Susquehanna International Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Sell
1,580,600
-327,200
-17% -$2.97M ﹤0.01% 2755
2025
Q4 		$12.8M Sell
1,907,800
-261,300
-12% -$1.97M ﹤0.01% 2726
2025
Q3 		$18.8M Buy
2,169,100
+953,200
+78% +$7.42M ﹤0.01% 2277
2025
Q2 		$7.66M Sell
1,215,900
-115,200
-9% -$763K ﹤0.01% 3240
2025
Q1 		$8.53M Sell
1,331,100
-577,800
-30% -$4.78M ﹤0.01% 2745
2024
Q4 		$15.3M Sell
1,908,900
-417,400
-18% -$4.02M ﹤0.01% 2132
2024
Q3 		$29.4M Buy
2,326,300
+76,900
+3% +$993K 0.01% 1477
2024
Q2 		$28.5M Buy
2,249,400
+517,600
+30% +$5.21M 0.01% 1406
2024
Q1 		$8.28M Buy
1,731,800
+14,700
+0.9% +$68.2K ﹤0.01% 2892
2023
Q4 		$8.24M Sell
1,717,100
-686,600
-29% -$4.2M ﹤0.01% 2907
2023
Q3 		$17.4M Buy
2,403,700
+345,100
+17% +$2.76M ﹤0.01% 1892
2023
Q2 		$15.3M Sell
2,058,600
-908,700
-31% -$7.15M ﹤0.01% 2003
2023
Q1 		$20.6M Buy
2,967,300
+1,022,100
+53% +$9.4M ﹤0.01% 1678
2022
Q4 		$20M Buy
1,945,200
+739,700
+61% +$13.1M 0.01% 1521
2022
Q3 		$21.9M Sell
1,205,500
-101,000
-8% -$4.38M 0.01% 1349
2022
Q2 		$67.2M Buy
1,306,500
+379,000
+41% +$19.6M 0.02% 691
2022
Q1 		$68.3M Sell
927,500
-1,034,400
-53% -$92.2M 0.01% 848
2021
Q4 		$281M Buy
1,961,900
+881,500
+82% +$151M 0.04% 363
2021
Q3 		$224M Sell
1,080,400
-266,900
-20% -$58.8M 0.03% 466
2021
Q2 		$286M Sell
1,347,300
-283,400
-17% -$51.9M 0.04% 372
2021
Q1 		$296M Buy
1,630,700
+140,700
+9% +$28M 0.05% 334
2020
Q4 		$166M Buy
1,490,000
+217,500
+17% +$23.1M 0.03% 474
2020
Q3 		$138M Buy
1,272,500
+60,800
+5% +$7.41M 0.03% 458
2020
Q2 		$101M Buy
1,211,700
+568,700
+88% +$21.8M 0.02% 499
2020
Q1 		$8.73M Sell
643,000
-430,400
-40% -$3.64M ﹤0.01% 1886
2019
Q4 		$4.27M Buy
1,073,400
+220,200
+26% +$955K ﹤0.01% 3202
2019
Q3 		$4.28M Sell
853,200
-320,600
-27% -$1.75M ﹤0.01% 2932
2019
Q2 		$6.88M Buy
1,173,800
+1,088,925
+1,283% +$8.57M ﹤0.01% 2318
2019
Q1 		$935K Buy
84,875
+42,660
+101% +$1.35M ﹤0.01% 5173
2018
Q4 		$1.55M Buy
42,215
+23,170
+122% +$898K ﹤0.01% 3918
2018
Q3 		$716K Sell
19,045
-8,270
-30% -$233K ﹤0.01% 5887
2018
Q2 		$732K Sell
27,315
-9,605
-26% -$325K ﹤0.01% 6044
2018
Q1 		$1.55M Buy
36,920
+31,470
+577% +$1.26M ﹤0.01% 4392
2017
Q4 		$135K Buy
5,450
+1,180
+28% +$28.8K ﹤0.01% 8558
2017
Q3 		$97K Sell
4,270
-2,945
-41% -$65.9K ﹤0.01% 8373
2017
Q2 		$166K Sell
7,215
-4,175
-37% -$81.9K ﹤0.01% 8436
2017
Q1 		$292K Buy
11,390
+2,750
+32% +$75.6K ﹤0.01% 7375
2016
Q4 		$218K Sell
8,640
-10,255
-54% -$299K ﹤0.01% 8530
2016
Q3 		$786K Sell
18,895
-12,990
-41% -$1.68M ﹤0.01% 5244
2016
Q2 		$4.64M Buy
31,885
+18,205
+133% +$2.09M ﹤0.01% 2310
2016
Q1 		$1.41M Sell
13,680
-5,530
-29% -$593K ﹤0.01% 4416
2015
Q4 		$3.22M Sell
19,210
-24,340
-56% -$3.75M ﹤0.01% 3162
2015
Q3 		$6.16M Sell
43,550
-2,335
-5% -$524K ﹤0.01% 2388
2015
Q2 		$10.2M Buy
45,885
+28,515
+164% +$5.01M ﹤0.01% 1971
2015
Q1 		$2.87M Buy
17,370
+13,380
+335% +$2.17M ﹤0.01% 3642
2014
Q4 		$473K Sell
3,990
-5,080
-56% -$531K ﹤0.01% 7315
2014
Q3 		$756K Sell
9,070
-18,620
-67% -$1.68M ﹤0.01% 6470
2014
Q2 		$2.56M Buy
27,690
+13,025
+89% +$1.14M ﹤0.01% 4190
2014
Q1 		$1.33M Buy
14,665
+2,730
+23% +$305K ﹤0.01% 5012
2013
Q4 		$1.22M Sell
11,935
-3,285
-22% -$232K ﹤0.01% 5142
2013
Q3 		$962K Buy
15,220
+9,310
+158% +$524K ﹤0.01% 5335
2013
Q2 		$243K Buy
+5,910
New +$256K ﹤0.01% 7156

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's NVAX Position: Q1 2026 in Review

Susquehanna International Group increased its Novavax (NVAX) stake by 93% in Q1 2026, buying an estimated $3.66M and bringing the position to 834,842 shares worth $6.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3719.

Susquehanna International Group first reported a position in NVAX in Q3 2013 and has held it in 48 quarters since. The position peaked at $284M in Q3 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Susquehanna International Group held 834,842 shares of Novavax worth $6.8M as of Q1 2026.
  • Susquehanna International Group bought 403,223 Novavax shares in Q1 2026, an estimated $3.66M.
  • Novavax made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3719 holding.
  • Susquehanna International Group first reported a position in Novavax in Q3 2013 and has held it in 48 quarters since.
  • Susquehanna International Group's Novavax position peaked at $284M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.